Fate Therapeutics
FATE
FATE
60 hedge funds and large institutions have $86.2M invested in Fate Therapeutics in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
24% less capital invested
Capital invested by funds: $114M → $86.2M (-$27.7M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
60
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.1M | |
| 2 | +$1.78M | |
| 3 | +$1.44M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.08M |
| 5 |
6CM
683 Capital Management
New York
|
+$383K |
Top Sellers
| 1 | -$5.03M | |
| 2 | -$1.82M | |
| 3 | -$462K | |
| 4 |
SCM
Segantii Capital Management
Hong Kong
|
-$182K |
| 5 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$160K |